In the phase 3 multicenter, open-label, randomized CLEAR trial, lenvatinib in combination with pembrolizumab or everolimus demonstrated significant benefits over sunitinib in patients with advanced renal cell carcinoma (RCC)....
Read More1) In an updated analysis of the phase 2 DESTINY-Breast01 study, women with HER2-positive metastatic breast cancer ADC trastuzumab deruxtecan (Enhertu) continued to demonstrate favorable data, including a median progression-free...
Read More
Test your knowledge on SABCS 2020 – take our quiz and see how you compare with your...
Read More
Childhood and onset of allergic asthma are strongly associated, but only a few studies have...
Read More
The National Institutes of Health (NIH) recently announced 19 recommendations for the diagnosis,...
Read MorePembrolizumab plus axitinib is superior to sunitinib for the treatment of patients with treatment-naïve, advanced renal cell carcinoma (RCC), according to the most recent exploratory analysis of data from the KEYNOTE-426 study....
Read More[spreaker type=player resource=”episode_id=43864335″ theme=”light” autoplay=”false” playlist=”false” width=”100%” height=”200px”]
Read MoreThank you for taking our quiz! How did you do? 1) According to an AAO IRIS® Registry Analysis, the overall prevalence of dry eye disease (DED) was about 30% in patients 3 months prior cataract surgery, but only what percent of...
Read More
It’s no question that advancements in the treatment of dry eye were impressive at AAO 2020....
Read More
It’s no question that advancements in the treatment of age-related macular degeneration were...
Read More
Omalizumab is a safe and effective therapy for elderly patients with urticaria who present with...
Read More
Researchers found that in a studied group of children, there was a tendency for higher D-dimer...
Read More
By Physician’s Weekly Blogger, Skeptical Scalpel Pop quiz: In the last 5years, how many people...
Read More
Differential diagnosis of allergic versus non-allergic asthma is typically made on the basis of...
Read More
Allergen immunotherapy (AIT) induces immunological tolerance, and there is increasing evidence of...
Read MoreWarren vs Dinter – Interview with Dr. MedLaw
Read More[spreaker type=player resource=”episode_id=43624976″ theme=”light” autoplay=”false” playlist=”false” width=”100%” height=”200px”]
Read More
Multiple studies have proven the benefits of omalizumab in patients with chronic spontaneous...
Read More[spreaker type=player resource=”episode_id=43534042″ theme=”light” autoplay=”false” playlist=”false” width=”100%” height=”200px”]
Read More
